Warning! GuruFocus detected
2 Severe warning signs
with PHR.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Pharmena SA
ISIN : PLPHRMN00011
Description
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 69.69 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 37.42 | |||||
| Beneish M-Score | -1.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EPS without NRI Growth Rate | 35.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.38 | |||||
| 9-Day RSI | 43.36 | |||||
| 14-Day RSI | 44.36 | |||||
| 3-1 Month Momentum % | 5.29 | |||||
| 6-1 Month Momentum % | -18.89 | |||||
| 12-1 Month Momentum % | -39.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.64 | |||||
| Quick Ratio | 15.77 | |||||
| Cash Ratio | 14.98 | |||||
| Days Inventory | 43.55 | |||||
| Days Sales Outstanding | 36.34 | |||||
| Days Payable | 122.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 19.72 | |||||
| 5-Year Yield-on-Cost % | 19.72 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 20.22 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.43 | |||||
| Operating Margin % | -390.46 | |||||
| Net Margin % | -16.42 | |||||
| FCF Margin % | -30.28 | |||||
| ROE % | -8.76 | |||||
| ROA % | -8.05 | |||||
| ROIC % | 1229.72 | |||||
| 3-Year ROIIC % | -62.1 | |||||
| ROC (Joel Greenblatt) % | -80.22 | |||||
| ROCE % | -3.63 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.88 | |||||
| PB Ratio | 4.09 | |||||
| Price-to-Tangible-Book | 4.14 | |||||
| EV-to-EBIT | -55.84 | |||||
| EV-to-EBITDA | -66.71 | |||||
| EV-to-Revenue | 3.79 | |||||
| EV-to-FCF | -12.53 | |||||
| Price-to-GF-Value | 0.87 | |||||
| Price-to-Projected-FCF | 1.47 | |||||
| Price-to-Median-PS-Value | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 4.31 | |||||
| Price-to-Net-Cash | 4.79 | |||||
| Earnings Yield (Greenblatt) % | -1.79 | |||||
| FCF Yield % | -6.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmena SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 9.846 | ||
| EPS (TTM) (zł) | -0.14 | ||
| Beta | 0.98 | ||
| 3-Year Sharpe Ratio | -0.39 | ||
| 3-Year Sortino Ratio | -0.51 | ||
| Volatility % | 36.5 | ||
| 14-Day RSI | 44.36 | ||
| 14-Day ATR (zł) | 0.176883 | ||
| 20-Day SMA (zł) | 4.437 | ||
| 12-1 Month Momentum % | -39.5 | ||
| 52-Week Range (zł) | 3.52 - 7.4 | ||
| Shares Outstanding (Mil) | 11.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmena SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmena SA Stock Events
| Event | Date | Price (zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmena SA Frequently Asked Questions
What is Pharmena SA(WAR:PHR)'s stock price today?
The current price of WAR:PHR is zł4.31. The 52 week high of WAR:PHR is zł7.40 and 52 week low is zł3.52.
When is next earnings date of Pharmena SA(WAR:PHR)?
The next earnings date of Pharmena SA(WAR:PHR) is .
Does Pharmena SA(WAR:PHR) pay dividends? If so, how much?
The Dividend Yield %  of Pharmena SA(WAR:PHR) is 19.72% (As of Today), Highest Dividend Payout Ratio of Pharmena SA(WAR:PHR) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Pharmena SA(WAR:PHR) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers